National Academies Press: OpenBook
« Previous: References
Suggested Citation:"Appendix A: Related Resources." National Academies of Sciences, Engineering, and Medicine. 2019. Examining the Impact of Real-World Evidence on Medical Product Development: Proceedings of a Workshop Series. Washington, DC: The National Academies Press. doi: 10.17226/25352.
×

Appendix A

Related Resources

The references listed below are papers, projects, and guidance documents that supported the planning of and discussions during each workshop in this series. References are separated by relevance to each of the three workshops, and the Proceedings—in Brief from workshops 1 and 2 produced by the National Academies of Sciences, Engineering, and Medicine as part of this activity are included as well. These references are intended to provide readers and real-world evidence stakeholders with additional context for the discussions that occurred during the workshops.

Workshop 1: Incentives

Berger, M., G. Daniel, K. Frank, A. Hernandez, M. McClellan, S. Okun, M. Overhage, R. Platt, M. Romine, S. Tunius, and M. Wilson. 2017. A framework for regulatory use of real-world evidence. Washington, DC: Duke-Margolis Center for Health Policy.

CDRH (Center for Devices and Radiological Health). 2017. Use of real-world evidence to support regulatory decision-making for medical devices: Guidance for industry and Food and Drug Administration staff. Rockville, MD: U.S. Food and Drug Administration.

CTTI (Clinical Trials Transformation Initiative). 2018. Project: Quality by Design. https://www.ctti-clinicaltrials.org/projects/quality-design (accessed November 6, 2018).

CTTI. 2018. Project: Real World Evidence. https://www.ctti-clinicaltrials.org/projects/real-world-evidence (accessed November 6, 2018).

NASEM (National Academies of Sciences, Engineering, and Medicine). 2017. Real-world evidence generation and evaluation of therapeutics: Proceedings of a workshop. Washington, DC: The National Academies Press. doi: https://doi.org/10.17226/24685.

NASEM. 2018. Examining the impact of real-world evidence on medical product development: I. Incentives: Proceedings of a workshop—in brief. Washington, DC: The National Academies Press. doi: https://doi.org/10.17226/25024.

Suggested Citation:"Appendix A: Related Resources." National Academies of Sciences, Engineering, and Medicine. 2019. Examining the Impact of Real-World Evidence on Medical Product Development: Proceedings of a Workshop Series. Washington, DC: The National Academies Press. doi: 10.17226/25352.
×

National Health Council. 2017. Patient perspectives on real-world evidence: A roundtable to gather views, needs, and recommendations. Washington, DC: National Health Council.

Sherman, R. E., S. A. Anderson, G. J. Dal Pan, G. W. Gray, T. Gross, N. L. Hunter, L. LaVange, D. Marinac-Dabic, P. W. Marks, M. A. Robb, J. Shuren, R. Temple, J. Woodcock, L. Q. Yue, and R. M. Califf. 2016. Real-world evidence—what is it and what can it tell us? New England Journal of Medicine 375(23):2293-2297.

Workshop 2: Practical Approaches

NASEM (National Academies of Sciences, Engineering, and Medicine). 2018. Examining the impact of real-world evidence on medical product development: II. Practical approaches: Proceedings of a workshop—in brief. Washington, DC: The National Academies Press. doi: https://doi.org/10.17226/25176.

Workshop 3: Application

CTTI (Clinical Trials Transformation Initiative). 2018. Project: Mobile Technologies. https://www.ctti-clinicaltrials.org/projects/mobile-technologies (accessed November 6, 2018).

Daniel, G., C. Silcox, J. Bryan, M. McClellan, M. Romine, and K. Frank. 2018. Characterizing RWD quality and relevancy for regulatory purposes. Washington, DC: Duke-Margolis Center for Health Policy.

FDA (U.S. Food and Drug Administration). 2013. Guidance for industry and FDA staff: Best practices for conducting and reporting pharmacoepidemiologic safety studies using electronic healthcare data. Rockville, MD: FDA.

FDA. 2013. Guidance for industry: Electronic source data in clinical investigations. Rockville, MD: FDA.

FDA. 2016. Use of electronic informed consent—questions and answers: Guidance for institutional review boards, investigators, and sponsors. Rockville, MD: FDA.

FDA. 2018. Use of electronic health record data in clinical investigations: Guidance for industry. Rockville, MD: FDA.

FOCR (Friends of Cancer Research). 2018. Establishing a framework to evaluate real-world endpoints. Washington, DC: Friends of Cancer Research.

Innovative Medicines Initiative GetReal. 2018. Deliverables. http://www.imi-getreal.eu/Publications/Deliverables-and-reports (accessed November 6, 2018).

Izurieta, H. S., M. Wernecke, J. Kelman, S. Wong, R. Forshee, D. Pratt, Y. Lu, Q. Sun, C. Jankosky, P. Krause, C. Worrall, T. MaCurdy, and R. Harpaz. 2017. Effectiveness and duration of protection provided by the live-attenuated herpes zoster vaccines in the Medicare population ages 65 years and older. Clinical Infectious Diseases 64(6):785-793.

Kimmelman, J., and A. J. London. 2015. The structure of clinical translation: Efficiency, information, and ethics. Hastings Center Report 45(2):27-39.

UK Academy of Medical Sciences and the Association of the British Pharmaceutical Industry. 2015. Real world evidence. London, England: UK Academy of Medical Sciences and the Association of the British Pharmaceutical Industry.

UK Academy of Medical Sciences FORUM. 2018. Next steps for using real world evidence. London, England: UK Academy of Medical Sciences.

Suggested Citation:"Appendix A: Related Resources." National Academies of Sciences, Engineering, and Medicine. 2019. Examining the Impact of Real-World Evidence on Medical Product Development: Proceedings of a Workshop Series. Washington, DC: The National Academies Press. doi: 10.17226/25352.
×
Page 181
Suggested Citation:"Appendix A: Related Resources." National Academies of Sciences, Engineering, and Medicine. 2019. Examining the Impact of Real-World Evidence on Medical Product Development: Proceedings of a Workshop Series. Washington, DC: The National Academies Press. doi: 10.17226/25352.
×
Page 182
Next: Appendix B: Workshop One Agenda »
Examining the Impact of Real-World Evidence on Medical Product Development: Proceedings of a Workshop Series Get This Book
×
Buy Paperback | $65.00 Buy Ebook | $54.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Randomized controlled trials (RCTs) have traditionally served as the gold standard for generating evidence about medical interventions. However, RCTs have inherent limitations and may not reflect the use of medical products in the real world. Additionally, RCTs are expensive, time consuming, and cannot answer all questions about a product or intervention. Evidence generated from real-world use, such as real-world evidence (RWE) may provide valuable information, alongside RCTs, to inform medical product decision making.

To explore the potential for using RWE in medical product decision making, the National Academies of Sciences, Engineering, and Medicine planned a three-part workshop series. The series was designed to examine the current system of evidence generation and its limitations, to identify when and why RWE may be an appropriate type of evidence on which to base decisions, to learn from successful initiatives that have incorporated RWE, and to describe barriers that prevent RWE from being used to its full potential. This publication summarizes the discussions from the entire workshop series.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!